Steering Committees

Steering Committee Meetings

MphaR Our Services Steering Committees

Steering Committees play an essential role in guiding scientific direction, shaping evidence-generation priorities, and ensuring that medical strategies remain aligned with real-world clinical needs. MphaR provides comprehensive support for the design, coordination, and execution of Steering Committee programs—before, during, and after major medical congresses.

Our structured, multi-meeting approach helps organizations continuously refine scientific plans, validate clinical data interpretations, and co-develop meaningful initiatives that improve patient care within a therapeutic area.

Objectives of a Steering Committee

Steering Committees bring together leading experts to:
  • Discuss and interpret emerging data presented at medical congresses
  • Review clinical implications and relevance across patient populations
  • Identify evidence gaps and strategic needs within the therapeutic landscape
  • Deep-dive into solutions to optimize patient care pathways
  • Provide expert guidance for white papers, publications, and evidence-generation plans
This trusted expert forum ensures that strategy decisions are informed by top scientific minds. 

How We Support Steering Committees

1. Preparation Stage

We manage all scientific and operational preparation, including:

  • Steering Committee member onboarding and briefing
  • Drafting and refining meeting materials (agendas, slides, questions)
  • Securing compliance approvals
  • Aligning objectives and expected outputs
This ensures every meeting is focused, efficient, and compliant.

2. Execution Stage

We deliver both live and asynchronous Steering Committee formats, supported by our digital tools

Asynchronous Discussions: Experts participate over several days or weeks—ideal for thoughtful, detailed input across global time zones.

Live Meeting: Moderated virtual or in-person sessions ensure direct dialogue, debate, and strategic decision-making.

Our scientific and technical team supports: 
  • Moderation and facilitation 
  • Real-time insight capture 
  • Polling, surveys, and interactive tools 
  • Document annotation and collaborative problem-solving 

3. Post-Event Stage

Following the meeting, MphaR transforms expert insights into clear, actionable outputs:
  • Key takeaways and strategic recommendations
  • Consolidated summaries or minutes
  • Final reports supporting internal decision-making and future planning
This ensures that insights are captured precisely and can be used effectively by Medical Affairs teams.

Built Around Key Congress Milestones

We structure Steering Committee activities around major global congresses (e.g., ASCO, ESMO, SABCS, ASH), ensuring regular expert input during periods of critical scientific updates.

A typical sequence may include:
Pre-Congress Meeting
Agenda-setting, reviewing anticipated data
Post-Congress Meeting
Interpreting new results and clinical impact
Follow - Up Meeting
Refining actions and next-phase planning  

This multi-touchpoint approach keeps strategy aligned with the evolving scientific landscape. 

Why Partner With MphaR?

What HCPs and Medical Affairs Experts Tell About Working with Us

We work closely with HCPs and Medical Affairs experts worldwide. Here’s what they share about partnering with MphaR
Trusted by Industry Leaders

Medical Affairs Trends: Blog, Digest and Podcasts

Stay informed on emerging Medical Affairs trends with expert blog articles, and twice-monthly editions of our Medical Affairs Digest and podcasts series.

TrendWatch: Medical Affairs

Explore concise articles covering the latest trends and innovations in Medical Affairs

Latest Article

Beyond the Search Bar: How AI Is Turning Literature Reviews Into Scientific Strategy for Medical Affairs

The article explains how artificial intelligence is transforming literature review in Medical Affairs from a manual, time-intensive activity into a faster, intelligence-driven process. As scientific publications, conference abstracts, and real-world evidence continue to expand, AI technologies such as natural language processing and machine learning enable continuous evidence monitoring, automated categorization, and rapid summarization of relevant research. By helping teams identify emerging trends, prioritize high-impact evidence, and detect important scientific signals, AI allows Medical Affairs professionals to focus more on interpretation, strategic planning, and evidence-based decision-making. While AI improves efficiency and scalability, human oversight remains essential to validate sources, assess context, and ensure scientific accuracy and integrity. Ultimately, AI-supported literature review enhances the ability of Medical Affairs teams to generate meaningful insights and respond proactively to an increasingly complex scientific landscape.

Same Company, Different Outcomes: Why AI Adoption in Medical Affairs Comes Down to the Team

The article explains how building digital confidence is becoming essential for successful AI adoption in Medical Affairs. While AI is increasingly being used for activities such as literature monitoring, insight generation, evidence planning, and stakeholder engagement, the greatest value comes not from technology alone but from teams that can use it effectively and responsibly. AI readiness varies across organizations, with teams progressing from awareness and experimentation to routine application and full strategic integration. By combining AI tools with strong scientific judgment, Medical Affairs professionals can improve efficiency, uncover meaningful insights, and support more informed decision-making. Successful adoption requires ongoing education, structured governance, critical evaluation of AI outputs, and a culture that encourages learning and responsible innovation. Ultimately, the future of Medical Affairs will be shaped not by AI replacing expertise, but by digitally confident professionals who can combine human judgment with machine intelligence to drive scientific and strategic impact.

From Gatekeeper to Game-Changer: The Digital Transformation of Medical Affairs Compliance

The article explains how artificial intelligence and digital technologies are transforming compliance within Medical Affairs, shifting it from a slow, manual review process into a streamlined, automated, and workflow-integrated function. As the volume of scientific content and regulatory complexity continues to increase, AI-powered compliance platforms enable rapid identification of risk language, verification of claims, and detection of inconsistencies at scale. By embedding governance directly into content creation workflows—through automated MLR review, real-time audit trails, and standardized approval processes—compliance evolves from a final checkpoint into a continuous, compliant-by-design capability. This transformation enhances speed, consistency, and transparency while maintaining high standards of scientific and regulatory integrity. Supported by digital literacy, workflow optimization, and strong governance frameworks, compliance becomes an enabler rather than a barrier to scientific communication. Despite challenges related to implementation, skills gaps, and regulatory expectations, the integration of AI positions Medical Affairs compliance as a strategic asset that accelerates decision-making, strengthens credibility, and supports scalable, high-quality scientific engagement.

Bi-monthly Newsletter: Medical Affairs Digest

Your bi-monthly overview of essential Medical Affairs updates and emerging industry signals

Latest Newsletter
Bi-Monthly podcasts: Medical Affairs Voices

Listen to expert conversations exploring current trends and future directions in Medical Affairs

Precision Medicine in Oncology: Transforming Cancer Diagnostics Using AI Tools

In this episode, we uncover how artificial intelligence is transforming oncology, marking a shift from standardizedtreatments to precision medicine tailored to each patient’s genetic and molecular profile. From AI-powered imaging and digital pathology to genomic analysis and liquid biopsies, technology is reshaping how cancer is detected, understood, and treated. Hear how these innovations are driving earlier diagnoses, improving treatment accuracy, and empowering clinicians with insights once thought impossible. We also explore the ethical and practical challenges of integrating AI into cancercare and what it means for patients and providers alike. Join us as we look ahead to a future where AI doesn’t replace the human touch—it amplifies it, bringing us closer to truly personalized oncology care.

Leveraging AI and NLP to Transform Medical Information Systems in Medical Affairs

In this episode, we explore how artificial intelligence and natural language processing are reshaping how Medical Affairs teams manage, interpret, and apply vast volumes of unstructured medical information. From scientific literature and safety reports to advisory board insights and field intelligence, NLP is turning free text into structured, actionable knowledge—helping teams move faster while maintaining scientific rigor. Discover how NLP is being applied across literature intelligence, medical information systems, pharmacovigilance, and stakeholder engagement, and why human oversight remains essential in regulated medical environments. We also examine the risks, ethical considerations, and governance frameworks needed to ensure accuracy, transparency, and compliance. Join us as we look ahead to the evolution from language processing to true language understanding—and what this shift means for the future of Medical Affairs as a strategic, insight-driven function.

From Data to Dialogue — Strengthening Patient-Centricity Through Virtual Advisory Boards

In this episode, we examine how Virtual Advisory Boards are revolutionizing patient engagement, turning static data into meaningful dialogue that shapes real-world decisions. As patient-centricity becomes a defining principle in modern pharma, digital platforms are creating space for authentic collaboration between patients, caregivers, and industry leaders. Discover how virtual formats remove barriers to participation, ensure inclusivity, and make continuous patient input a practical reality. We’ll explore how the MphaR Virtual Advisory Board platform enables companies to integrate patient insights into trial design, treatment strategies, and beyond. Tune in as we explore how the future of patient engagement is being built—one conversation at a time—through innovation, empathy, and dialogue that truly puts patients at the center of healthcare.

Follow MphaR on Social Media:

MphaR Our Services Steering Committees

FAQs

Yes. We provide expert identification, profiling, and justification to ensure the committee includes the most relevant specialities.
Absolutely. We prepare agendas, discussion guides, and scientific materials, and we can also facilitate the sessions.
×

Thank you! Your message has been sent.

    Get Case Study

    Improving the treatment care of patients with Multiple Myeloma through regular digital connection between International, National Experts and haematologists in Europe

      Get Brochure